In silico exploration of novel EGFR-targeting compounds: integrative molecular modeling, docking, pharmacokinetics, and MD simulations for advancing anti-cervical cancer therapeutics
2025Scientific ReportsJournalOpen access
10.1038/s41598-025-91135-4Full text14 citations